Bottom line
Is PPAEX a good fund? The bottom line
PPAEX is the Class I share class of GMO U.S. Opportunistic Value Fund, an actively managed large value mutual fund from Gmo.
It charges 0.61% — about $61 a year on every $10,000 invested, cheaper than 72% of large value funds we track.
It returned +14.6% over one year (as of Dec 31, 2025, per its prospectus).
With $324 million in net assets and 166 holdings, its largest position is Meta Platforms Inc (5.2%) and the top 10 make up 28.2% of the portfolio.
Updated Nov 19, 2026
What PPAEX invests in
Total return.
"GMO seeks to achieve the Funds investment objective by investing the Funds assets primarily in securities traded in U.S. equity markets. GMO selects the securities the Fund buys and sells based on its evaluation of companies published financial information, securities prices, equity and other markets, the overall global economy, and governmental policies. The Fund seeks to capitalize opportunistically on what GMO believes to be market dislocations within the U.S. equity markets. In selecting securities for the Fund, GMO uses a combination of proprietary quantitative investment methods to identify U.S. equities GMO believes have positive return potential relative to other U.S. equities. A key component of the process is GMOs proprietary methodology for assessing values of company tangible and intangible assets and generating equity return forecasts, which are then incorporated into…
From the fund's prospectus (filed Oct 20, 2026).
PPAEX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| PPAEX | +14.6% | — | — |
| Large Value median | +13.6% | +11.3% | +10.2% |
Source: Fund prospectus, as of Dec 31, 2025
What PPAEX costs
On a $10,000 investment, PPAEX's 0.61% expense ratio costs about $61 a year. The prospectus estimates $829 in total costs over 10 years (assuming 5% annual returns). The median large value fund charges 0.81%.
PPAEX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Meta Platforms Inc | 5.16% |
| 2 | Alphabet Inc | 3.88% |
| 3 | QUALCOMM Inc | 3.35% |
| 4 | Merck & Co Inc | 2.67% |
| 5 | Exxon Mobil Corp | 2.57% |
| 6 | Verizon Communications Inc | 2.36% |
| 7 | Bank of America Corp | 2.15% |
| 8 | Pfizer Inc | 2.09% |
| 9 | UnitedHealth Group Inc | 2.02% |
| 10 | Johnson & Johnson | 1.97% |
Source: SEC Form N-PORT, period ended May 31, 2026
The top 10 make up 28.2% of the fund. See all top 25 holdings and asset mix →